* Syneos Health Inc SYNH.OQ SYNH.O is expected to show a
fall
in quarterly revenue when it reports results on February 16.
* The Morrisville North Carolina-based company is expected
to
report a 6.1% decrease in revenue to $1.289 billion from $1.37
billion a year ago, according to the mean estimate from 10
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Syneos Health Inc
is for
earnings of $1.20 per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 8
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Syneos
Health Inc
is $34, below its last closing price of $34.65.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Sep. 30 2022 1.32 1.32 1.23 Missed -6.5
Jun. 30 2022 1.20 1.20 1.25 Beat 4.6
Mar. 31 2022 0.95 0.95 1.01 Beat 6.5
Dec. 31 2021 1.43 1.43 1.48 Beat 3.2
Sep. 1.17 1.17 1.22 Beat 4.4
30 2021
Jun. 30 2021 0.95 0.95 0.97 Beat 2.4
Mar. 31 2021 0.74 0.75 0.79 Beat 5.8
Dec. 31 2020 1.10 1.10 1.11 Beat 0.6
This summary was machine generated February 14 at 14:42 GMT.
All figures in US dollars unless otherwise stated